How has the PFS industry adapted to the shift towards connectivity and digital health

Top Quote SMi Reports: Now in its 8th year, the Pre-Filled Syringes East Coast virtual conference will bring together international industry experts in the field. End Quote
  • (1888PressRelease) April 02, 2021 - We continue to witness significant growth and innovation in the pre-filled syringe and injection device market as well as evolution of the regulatory landscape.

    Delegates stand to gain many valuable insights from Pre-filled Syringes East Coast 2021 including:
    - Industry updates on device design, platforms and integrated development for PFS and combination products
    - International regulatory updates and guidance for the pre-filled syringes industry

    Also, on this year’s agenda we will be covering the following main topics over the two-day virtual conference:
    • Advancing development for drug delivery devices
    • How has the PFS industry adapted to the shift towards connectivity and digital health
    • Container closure integrity and compatibility

    The brochure with the full agenda and speaker line up for the main conference is available to download:

    Key presentations from Kristina Lauritsen, FDA and Megan K. Doyle, Amgen discussing:

    An FDA perspective on the acceleration towards
    • The pre-filled syringes industry’s continued growth and commitment in advancing the use of technology, software and wearables
    • A review of current regulatory guidance for PFS and combination products
    • A review of current guidance for connected devices and FDA’s new digital health center of excellence
    • The future of digital health in the PFS industry; what has changed in the past year and the key regulations to be considered
    Kristina Lauritsen, Combination Products Regulatory Advisor, CDER/FDA

    Connected Combination Products: The Industry Perspective
    • The industry is moving to incorporate digital components into combination products to improve the patient experience
    • Connected Combination Products are one way to accomplish this, but few have been approved to date
    • This presentation will address challenges in the development and review of connected combination products and other digital health priorities, from the industry perspective
    Megan K. Doyle, Global Policy Lead, Combination Products, Digital Health, and Diagnostics, Amgen

    Virtual conference:
    Online access only $499 applies to pharmaceutical and biotechnology companies (Limited time only)

    Sponsored by Almac, BD, Owen Mumford & Zeon

    For all media inquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: hsidhu ( @ ) smi-online dot co dot uk

    About SMi Group:
    Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

  • FB Icon Twitter Icon In-Icon
Contact Information